Growth hormone delivery system approved
New delivery device approved for somatropin (Saizen).
EMD Serono has received an FDA approval for Easypod, a novel delivery system for the administration of somatropin ([rDNA origin] Saizen). The device features preset dosing, which eliminates the need for patients to set their dose each day and also tracks the number of doses administered. Easypod is intended for use with Saizen Click.Easy cartridges. Saizen is indicated for the treatment of children and adults with growth hormone deficiency.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
